Author

Mostafa Yazdimamaghani

University of North Carolina at Chapel HillORCID 0000-0001-5090-9528Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alexander V. KabanoviD· 1 shared Chaemin LimiD· 1 shared Charles M. PerouiD· 1 shared Duhyeong HwangiD· 1 shared Jonathan Stuart SerodyiD· 1 shared Oleg V. Kolupaev· 1 shared Sonia J. LaurieiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alexander V. KabanovORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyBiomaterialsPeer-reviewedAug 8, 2024

Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy

Mostafa Yazdimamaghani, Oleg V. Kolupaev, Chaemin Lim…·Jonathan Stuart Serody

This study shows that combining nanoformulated TLR7/8 agonist and PI3K delta inhibitor with radiotherapy improves anti-tumor activity in TNBC by modulating the tumor microenvironment.

35 citationstop 3%

mousebulk RNA-seq

𝕏 PostBluesky